Fludeoxyglucose (F-18) 232 Gbq (Fludeoxyglucose 18f SOLUTION) 232 GBQ

Fludeoxyglucose (F-18) 232 GBQ is a radiopharmaceutical solution used in medical imaging. This intravenous solution is designed for diagnostic purposes, often in positron emission tomography (PET) scans.

Strength

232 GBQ

Pack Size

20ML

Manufacturer / TM Owner

LAWSON HEALTH RESEARCH INSTITUTE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fludeoxyglucose (F-18) is primarily used in PET imaging to help detect and monitor conditions like cancer, heart disease, and brain disorders. It works by highlighting areas of high metabolic activity, aiding in the visualization of abnormal tissues. This radiopharmaceutical is often employed to assess the extent and activity of tumors, evaluate heart function, and identify regions of the brain affected by conditions such as Alzheimer's disease.

Side Effects

Fludeoxyglucose (F-18) is designed to be administered intravenously and is typically well-tolerated. Common effects may include temporary discomfort at the injection site. As with any medical procedure, individual responses can vary, and it is important to follow the guidance of healthcare professionals.

Precautions & Warnings

Fludeoxyglucose (F-18) should be handled with care due to its radioactive nature. It is essential to follow strict safety protocols to minimize exposure. Pregnant women and individuals with certain medical conditions should consult their healthcare provider before use. Proper disposal of radioactive materials is crucial to ensure safety.

Avoid Interactions

Fludeoxyglucose (F-18) may interact with other medications or substances. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the results of the PET scan, so specific dietary restrictions may be advised.

Frequently Asked Questions

Fludeoxyglucose (F-18) is used in PET imaging to detect and monitor conditions like cancer, heart disease, and brain disorders.

Fludeoxyglucose (F-18) is administered intravenously by healthcare professionals in a controlled medical setting.

Common effects may include temporary discomfort at the injection site. Individual responses can vary.

Fludeoxyglucose (F-18) should be handled with care due to its radioactive nature. Pregnant women and individuals with certain medical conditions should consult their healthcare provider.

Fludeoxyglucose (F-18) may interact with other medications. It is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.